Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive Esophagitis (Q66083564)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive Esophagitis |
clinical trial |
Statements
A Phase 3 Study to Evaluate the Efficacy and Safety of Dexlansoprazole (60 mg QD) and an Active Comparator, Lansoprazole (30 mg QD) on Healing of Erosive Esophagitis, and Maintenance of Healing in Subjects With Healed Erosive Esophagitis With Dexlansoprazole (30 mg QD) and Placebo (English)
0 references
21 December 2016
0 references
16 October 2017
0 references
37
0 references
18 year
0 references